Evaluation on Clinical Effects and Outcomes of Increased Hydrophilicity by Plasma Treatment to Microporous Titanium-coated Femoral Stems in Total Hip Arthroplasty

The Catholic University of Korea, Seoul St. Mary's Hospital0 个研究点目标入组 120 人开始时间: 待定最近更新: 2022年9月20日

试验速览

暂无简介。

•1. Has hip fractures requiring total hip arthroplasty
•2. Has Active infections including sepsis and osteomyelitis in joint lesions.
•3. Has low bone stock or osteoporosis which requires cemented fixation of acetabular cups
•4. Has Metabolic disorders which can alter bone formation metabolism
•5. Has osteomalacia
•6. Possesses infection foci which can potentially spread to the hip joint
•7. Confirmed rapid joint destruction, prominent bone loss or osteolysis on preoperative X-rays.
•8. Has Vascular insufficiency or neuromuscular disorders including muscular dystrophy, which can undermine outcomes of arthroplasty
•9. Has any concomitant disease which is likely to jeopardize the functioning or success of the implant
•10. Has a known sensitivity or allergy to one or more of the implanted materials, including but not limited to chromium, cobalt, and/or ceramic
•11. Is a prisoner, known alcohol or drug abuser or mentally incompetent or unable to understand what participation in this study entails
•12. Has participated to other clinical trials within 6 months period at time of the screening
•13. Has been determined to be ineligible to participate in the trial

发起方